Anticancer research · 2015
Hyaluronic Acid Inhibitor 4-Methylumbelliferone Activates the Intrinsic Apoptosis Pathway in K562 Chronic Myelogenous Leukemia Cells.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ban Hao, Uchakina Olga, McKallip Robert James
Аннотация
BACKGROUND: As an inhibitor of hyaluronic acid (HA) synthesis, 4-methylumbelliferone (4-MU) has been shown to induce apoptosis of various types of cancer cells. However, the potential impact of 4-MU-induced apoptosis on leukemia cells via modulation of HA is not well-known.
MATERIALS AND METHODS: We examined apoptosis of chronic myelogenous leukemia (CML) cells after treatment with 4-MU using annexin V/propidium iodide (V/PI) analysis and poly (ADP-ribose) polymerase (PARP) cleavage. We further examined the mechanisms of 4-MU-induced apoptosis by measuring mitochondrial membrane potential and reactive oxygen species generation. Using real-time PCR, and western blot analysis we examined signaling pathways involved in apoptosis.
RESULTS: The current study demonstrated that treatment of CML cells with 4-MU led to induction of apoptosis through PARP cleavage and loss of mitochondria membrane potential. Mechanistically, 4-MU led to increased p53 mRNA expression, elevated cytoplasmic protein levels of cytochrome c and B-cell lymphoma-2-associated X (BAX) and reduced levels of B-cell lymphoma-2 (BCL2) expression. Addition of exogenous soluble HA was able to protect 4-MU-exposed cells from apoptosis.
CONCLUSION: Our findings suggest that 4-MU induces apoptosis in CML cells by activating components associated with the intrinsic apoptosis pathway.
MATERIALS AND METHODS: We examined apoptosis of chronic myelogenous leukemia (CML) cells after treatment with 4-MU using annexin V/propidium iodide (V/PI) analysis and poly (ADP-ribose) polymerase (PARP) cleavage. We further examined the mechanisms of 4-MU-induced apoptosis by measuring mitochondrial membrane potential and reactive oxygen species generation. Using real-time PCR, and western blot analysis we examined signaling pathways involved in apoptosis.
RESULTS: The current study demonstrated that treatment of CML cells with 4-MU led to induction of apoptosis through PARP cleavage and loss of mitochondria membrane potential. Mechanistically, 4-MU led to increased p53 mRNA expression, elevated cytoplasmic protein levels of cytochrome c and B-cell lymphoma-2-associated X (BAX) and reduced levels of B-cell lymphoma-2 (BCL2) expression. Addition of exogenous soluble HA was able to protect 4-MU-exposed cells from apoptosis.
CONCLUSION: Our findings suggest that 4-MU induces apoptosis in CML cells by activating components associated with the intrinsic apoptosis pathway.